Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Biomia Aps logo — Nature's pharmacy, re-engineered

Biomia Aps

Nature's pharmacy, re-engineered

Founded 2022 Denmark Denmark 7 employees Pre-Seed Total: $3.00M Biotechnology, Life Sciences

General Information

Company Name Biomia Aps
Founded Year 2022
Location Denmark Denmark
Employees 7
Industries Biotechnology, Life Sciences
Funding Stage Pre-Seed
Social

BounceWatch is an independent company data service, not affiliated with Biomia Aps. To contact Biomia Aps, visit biomia.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Biomia Aps compare?

A PDF of Biomia Aps and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Biomia Aps soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Biomia Aps

Biomia Aps is a biotechnology startup based in Denmark that aims to revolutionize the healthcare industry with its synthetic biology approach. Founded in 2022, the company is committed to designing biology for sustainable health, focusing on developing a pipeline of plant-inspired natural or new-to-nature therapeutic products to address the unmet medical needs in pain, addiction, and mental health conditions. The latest milestone for Biomia Aps was its $3.00M Pre Seed Round investment led by Blue Yard Capital, Nucleus Capital, and Amino Collective on 26 September 2023. This injection of capital is poised to propel the company's innovative research and development efforts forward, potentially leading to groundbreaking advancements in the biotechnology and healthcare sectors. With its ambitious vision and strong backing from prominent investors, Biomia Aps is poised to make a meaningful impact in the industry, offering promising prospects for potential investors seeking opportunities in the burgeoning field of synthetic biology and sustainable healthcare solutions.

Business keywords: synthetic biology, plant-derived, therapeutic products, natural products, medicine, pain management, addiction treatment, mental health, drug development, bioengineering, sustainable health, pharmaceuticals, biomimicry, biomedical innovation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Pre Seed Round $3.00M 3
Blue Yard Capital Nucleus Capital Amino Collective
Blue Yard Capital, Nucleus Capital +1
26 Sep 2023

Biomia Aps Alternatives & Competitors

View All Alternatives
Biomia Aps vs
Awakn Life Sciences
Awakn Life Sciences Canada

Therapeutics for substance use and mental health disorders

Post-IPO Equity
10 employees
Biotechnology, Health Care
Biomia Aps vs
Psilera
Psilera United States

Welcome to a new era of mindful medicine.

11 employees
Biotechnology, Life Sciences
Biomia Aps vs
Exalys Therapeutics
Exalys Therapeutics

Creating breakthrough anti-inflammatory therapeutics to address urgent medical needs, starting with...

Series A
Biotechnology, Health and Wellness
View all alternatives

FAQ About Biomia Aps

Nature's pharmacy, re-engineered
Biomia Aps was founded in 2022.
Biomia Aps is headquartered in Denmark.
Biomia Aps operates in Biotechnology and Life Sciences. Its work centres on synthetic biology, plant-derived, therapeutic products and natural products.
Biomia Aps has approximately 7 employees.
Biomia Aps has completed 1 funding round, raising a total of $3.00M. The latest funding stage is Pre-Seed.
Top alternatives and competitors to Biomia Aps include Awakn Life Sciences, Psilera, Exalys Therapeutics, Lassen Therapeutics, Scorpion Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Biomia Aps and Awakn Life Sciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Biomia Aps, https://bouncewatch.com/company/biomia-aps, updated 21 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes